Our scientific team will provide comprehensive information aligned with your laboratory research objectives.
Advanced Metabolic Peptide
RETA-NX™ Retatrutide 120mg
- 1. Modulates GLP-1, GIP and glucagon pathways
- 2. Supports metabolic signaling pathway investigation
- 3. Explored in energy balance research models
- 4. Studied for endocrine system pathway modulation
- 5. Investigated in advanced metabolic regulation studies
RETA-NX™ Retatrutide 120mg
Precision Dose Guide — 300 Click Pen (professional reference)
PRODUCT SPECIFICATIONS
• Total content: 120mg RETA-NX™
• Pen volume: 3ml
• Mechanical capacity: 300 clicks
• Calibration: 0.4mg per click
Triple Agonist Profile: GLP-1 • GIP • Glucagon Receptor Agonist (Retratutide)
DOSAGE GUIDE - CLICK CONVERSION (MULTI-DOSE PEN)
Clicks
Equivalent Dose (mg)
Doses per Pen
10 clicks
4 mg
30 doses
15 clicks
6 mg
20 doses
20 clicks
8 mg
15 doses
25 clicks
10 mg
12 doses
30 clicks
12 mg
10 doses
Dosing Note: Each click ≈ 0.4mg of active compound.
Multi-dose pen with fractionated dosing capability.
Product Overview
Retatrutide is a synthetic multi-receptor agonist investigated in advanced metabolic research for its activity across three key hormonal signaling pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This tri-agonist profile makes it a focal compound in experimental models examining integrated metabolic regulation and endocrine signaling dynamics.
Retatrutide has been studied for its receptor-binding characteristics and downstream intracellular signaling cascades within controlled laboratory environments. Its multi-pathway engagement allows researchers to explore coordinated metabolic signaling, energy homeostasis mechanisms, and receptor-specific pathway modulation.
At Nexzya Bioscience, Retatrutide 120mg is produced under stringent research-grade standards. Each batch undergoes advanced analytical verification to confirm molecular identity, structural integrity, and purity specifications. Our quality assurance systems ensure reproducibility, batch consistency, and full traceability to support high-level metabolic research initiatives.
Key Characteristics
Synthetic triple receptor agonist peptide
Activity at GLP-1, GIP, and glucagon receptor pathways (research context)
Precisely defined amino acid sequence
High-purity research-grade formulation
Molecular identity verified via advanced analytical testing
Investigated for coordinated endocrine signaling modulation
Studied in metabolic pathway and receptor interaction models
Examined for downstream intracellular signaling dynamics
Stable under recommended laboratory storage conditions
Batch-specific analytical documentation available
Direct Research Applications & Potential Benefits
Supports investigation of multi-receptor metabolic signaling networks
Enables analysis of GLP-1/GIP/glucagon pathway interactions
Assists in studying integrated endocrine communication models
Contributes to experimental frameworks focused on energy regulation dynamics
Facilitates exploration of receptor-mediated metabolic pathway modulation
Final Overview
Retatrutide 120mg from Nexzya Bioscience reflects our commitment to molecular precision, scientific rigor, and research-grade reliability. Developed exclusively for controlled laboratory investigation, this compound adheres to strict validation standards to ensure consistent analytical performance across advanced metabolic research applications.
For laboratories seeking analytically verified multi-receptor agonist peptides for structured endocrine and metabolic signaling studies, Nexzya Bioscience delivers solutions grounded in quality assurance, traceability, and methodological excellence.
Request Technical Information
To receive detailed analytical reports, batch specifications, and technical documentation for Retatrutide 120mg, please complete the form below with your name and email.
Advanced Peptide Science & Biomolecular Research
South Korea — 대한민국
Czech Republic — Česká republika
Resources
NEXZYA™ Bioscience | Since 1986 All Rights Reserved